The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer
Long noncoding RNAs (lncRNA) have recently been associated with the development and
progression of a variety of human cancers. However, to date, the interplay between known …
progression of a variety of human cancers. However, to date, the interplay between known …
[PDF][PDF] The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer
R Malik, L Patel, JR Prensner, Y Shi, MK Iyer… - Mol Cancer Res, 2014 - Citeseer
Long noncoding RNAs (lncRNA) have recently been associated with the development and
progression of a variety of human cancers. However, to date, the interplay between known …
progression of a variety of human cancers. However, to date, the interplay between known …
The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer
R Malik, L Patel, JR Prensner, Y Shi… - Molecular Cancer …, 2014 - escholarship.org
UnlabelledLong noncoding RNAs (lncRNA) have recently been associated with the
development and progression of a variety of human cancers. However, to date, the interplay …
development and progression of a variety of human cancers. However, to date, the interplay …
[HTML][HTML] The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer
R Malik, L Patel, JR Prensner, Y Shi, M Iyer… - Molecular cancer …, 2014 - ncbi.nlm.nih.gov
Long noncoding RNAs (lncRNAs) have recently been associated with the development and
progression of a variety of human cancers. However, to date, the interplay between known …
progression of a variety of human cancers. However, to date, the interplay between known …
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer
R Malik, L Patel, JR Prensner, Y Shi… - Molecular Cancer …, 2014 - scholars.northwestern.edu
Long noncoding RNAs (lncRNA) have recently been associated with the development and
progression of a variety of human cancers. However, to date, the interplay between known …
progression of a variety of human cancers. However, to date, the interplay between known …
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
R Malik, L Patel, JR Prensner, Y Shi… - Molecular Cancer …, 2014 - europepmc.org
Implications This study identifies PCAT29 as the first androgen receptor-repressed lncRNA
that functions as a tumor suppressor and that its loss may identify a subset of patients at …
that functions as a tumor suppressor and that its loss may identify a subset of patients at …
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer
R Malik, L Patel, JR Prensner, Y Shi… - Molecular Cancer …, 2014 - augusta.elsevierpure.com
Long noncoding RNAs (lncRNA) have recently been associated with the development and
progression of a variety of human cancers. However, to date, the interplay between known …
progression of a variety of human cancers. However, to date, the interplay between known …
The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer
R Malik, L Patel, JR Prensner, Y Shi, MK Iyer… - Molecular Cancer …, 2014 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Long noncoding RNAs (lncRNA) have recently
been associated with the development and progression of a variety of human cancers …
been associated with the development and progression of a variety of human cancers …
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer
R Malik, L Patel, JR Prensner, Y Shi… - Molecular cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Long noncoding RNAs (lncRNA) have recently been associated with the development and
progression of a variety of human cancers. However, to date, the interplay between known …
progression of a variety of human cancers. However, to date, the interplay between known …
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
R Malik, L Patel, JR Prensner, Y Shi… - Molecular Cancer …, 2014 - europepmc.org
Implications This study identifies PCAT29 as the first androgen receptor-repressed lncRNA
that functions as a tumor suppressor and that its loss may identify a subset of patients at …
that functions as a tumor suppressor and that its loss may identify a subset of patients at …